Ortho-McNeil Pharmaceutical, Inc. and Johnson & Johnson Pharmaceutical Research and Development, LLC et al. v. Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.

首页> 外文期刊>Biotechnology Law Report >Ortho-McNeil Pharmaceutical, Inc. and Johnson & Johnson Pharmaceutical Research and Development, LLC et al. v. Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.

【24h】

Ortho-McNeil Pharmaceutical, Inc. and Johnson & Johnson Pharmaceutical Research and Development, LLC et al. v. Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.

机译：Ortho-McNeil制药有限公司和强生制药研究与开发有限公司等。 v。Mylan Laboratories Inc.和Mylan Pharmaceuticals Inc.

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biotechnology Law Report》 |2009年第5期|p.677-680|共4页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
入库时间 2022-08-17 23:34:35

相似文献

外文文献
中文文献
专利

1. Takeda Chemical Industries, Ltd. and Takeda Pharmaceuticals North America, Inc. v. Mylan Laboratories, Inc., Mylan Pharmaceuticals, Inc., and UDL Laboratories, Inc., and Alphapharm Pty., Ltd. and Genpharm, Inc. [J] . Biotechnology Law Report . 2009,第1期

机译：武田化学工业株式会社和武田制药北美公司诉Mylan Laboratories，Inc.，Mylan Pharmaceuticals，Inc.和UDL Laboratories，Inc.以及Alphapharm Pty。，Ltd.和Genpharm，Inc.。
2. Kaiser Foundation Health Plan Inc. v. Abbott Laboratories, Inc.; Geneva Pharmaceuticals Technology Corporation (No. 06-55687, D.C. No. CV-02-02443-JFW; No. 06-55748, D.C. No. CV-02-02443-JFW) [J] . Biotechnology Law Report . 2009,第2期

机译：Kaiser Foundation Health Plan Inc.诉Abbott Laboratories，Inc .；日内瓦制药技术公司（No. 06-55687，D.C. CV-02-02443-JFW; No. 06-55748，D.C. CV-02-02443-JFW）
3. A Design-Around Solution for a MMX-Based Tablet Drug Comprising Mesalazine-A Lesson from Shire Development, LLC v. Watson Pharmaceuticals, Inc. [J] . Chen Ping-Hsun Biotechnology Law Report . 2020,第1期

机译：关于MSAlazine的基于MMX的片剂药物的一种设计解决方案 - 来自Shire Deviopment的课程，LLC v。Watson Pharmaceuticals，Inc。
4. WILLIAM DAUBERT, ET UX., ETC., ET AL., PETITIONERS V.MERRELL DOW PHARMACEUTICALS, INC. SUPREME COURT OF THE UNITED STATES [C] . NAPARS anniversary conference;CATAIR anniversary conference;WATAI annual conference;ARC-CSI conference . -1

机译：威廉·道伯特（WILLIAM DAUBERT），ET UX。，ETC.，ET AL。，PETITIONERS V.MERRELL DOW PHARMACEUTICALS，INC。美国最高法院
5. Evaluating the corrective statements proposed in the court case U.S. Department of Justice vs. Philip Morris U.S.A. Inc., et al. [D] . Smith, Philip. 2009

机译：评估在美国司法部对Philip Morris U.S.A. Inc.等人的诉讼中提出的更正声明。
6. Opportunities for Electronic Health Record Data to Support Business Functions in the Pharmaceutical Industry—A Case Study from Pfizer Inc. [O] . Daijin Kim, Steven Labkoff, Samuel H. Holliday 2008

机译：电子病历数据支持制药业业务功能的机会—辉瑞公司的案例研究
7. The United Nations Convention on Contracts for the International Sale of Goods (u22CISGu22) and Geneva Pharmaceuticals Technology Corp. v. Barr Laboratories, Inc./Apothecon, Inc. v. Barr Laboratories, Inc.: The U.S. District Court for the Southern District of New Yorku27s Application and Interpretation of the Scope of the CISG [O] . Mattera Joseph D. 2004

机译：《联合国国际货物销售合同公约》和日内瓦制药技术公司诉Barr Laboratories，Inc./Apothecon，Inc.诉Barr Laboratories，Inc .：美国地方法院纽约南区对《销售公约》范围的适用和解释
8. Alpha List of Prime Contract Awards. Oct 92-Sep 93. FY93. (Jacobus Pharmaceutical Co. Inc. - Level 6 Systems Inc.). Part 11. [R] . 1994

机译：主要合同奖的alpha列表。 99年10月92日至9月93日。（Jacobus pharmaceutical Co. Inc. - Level 6 systems Inc.）。第11部分。

Ortho-McNeil Pharmaceutical, Inc. and Johnson & Johnson Pharmaceutical Research and Development, LLC et al. v. Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc.

著录项

相似文献

相关主题

期刊订阅